iCAD to Participate in the Guggenheim MedTech Disruptors Summit
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
NASHUA, N.H., Aug. 02, 2021 – iCAD, a leader in medical technology, announced participation in the Guggenheim MedTech Disruptors Summit. Michael Klein, Chairman and CEO, and Stacey Stevens, President, will engage in a fireside chat on August 10, 2021, at 10:00 AM Eastern Time. This event highlights iCAD's commitment to innovative cancer detection and therapy solutions. The company continues to lead advancements in medical technology from its Nashua, NH headquarters.
Details
News Market Reaction – ICAD
The recorded move for ICAD in the trading session of this news was +2.76%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
NASHUA, N.H., Aug. 02, 2021 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that Michael Klein, Chairman and Chief Executive Officer, and Stacey Stevens, President, will participate in a fireside chat at the Guggenheim MedTech Disruptors Summit, taking place virtually on August 9-10, 2021.
Fireside Chat Details
Date: August 10, 2021
Time: 10:00am Eastern Time
About iCAD, Inc.
Headquartered in Nashua, NH, iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. For more information, visit www.icadmed.com.
Contact:
Media Inquiries:
Jessica Burns, iCAD
+1-201-423-4492
jburns@icadmed.com
Investor Relations:
Jeremy Feffer, LifeSci Advisors
+ 1-212-915-2568
jeremy@lifesciadvisors.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.